1. Home /
  2. Drug Approvals

Drug Approvals

Moderna Shares Surge on Promising Vaccine Results

Let's check the charts and indicators.

Fed Heads: All Together Now, Market Outlook, Earnings, Lilly, AbbVie Talk Drugs

Why does the Fed as a whole appear to be unwilling to consider that they might be mistaken in the pace of their aggression?

NovoCure Gaps Sharply Higher for a Breakout: How to Play It

Let's check out the charts and indicators of both NovoCure and Zai Lab.

Expect Biotech to Head Higher in 2023

Let's dip into the biotech mailbag as the year comes to an end.

Pfizer May Not Be a Growth Play But It's a Good Stock for Tough Times

PFE is fundamentally sound and certainly not overvalued.

Merck's Stock Could Keep Climbing Higher

Here's what traders should do now.

Replimune Breaks Out: Could Rise 30% From Here

Let's check out the charts and indicators of this biotech name.

Is the Time Right to Buy Amgen After the Horizon Therapeutics Deal?

Here's the play traders can make.

Pacific Biosciences Has Made a Bottom Pattern: Prices to Watch

The stock bottomed in June/July and have worked higher.

BioVie Shares Higher on Alzheimer Data

Let's check the charts but be prepared for volatility.